Skip to main content

Published locations for NSCLC: Immune-related AEs during checkpoint inhibitor therapy may predict outcomes

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. NSCLC: Immune-related AEs during checkpoint inhibitor therapy may predict outcomes

User login

  • Reset your password
  • /content/nsclc-immune-related-aes-during-checkpoint-inhibitor-therapy-may-predict-outcomes
  • /fedprac/article/241131/lung-cancer/nsclc-immune-related-aes-during-checkpoint-inhibitor-therapy-may
  • /internalmedicinenews/article/241131/lung-cancer/nsclc-immune-related-aes-during-checkpoint-inhibitor
  • /oncologypractice/article/241131/lung-cancer/nsclc-immune-related-aes-during-checkpoint-inhibitor
  • /fedprac/avaho/article/241131/lung-cancer/nsclc-immune-related-aes-during-checkpoint-inhibitor
  • /jcomjournal/article/241131/lung-cancer/nsclc-immune-related-aes-during-checkpoint-inhibitor-therapy
  • /hematology-oncology/article/241131/lung-cancer/nsclc-immune-related-aes-during-checkpoint-inhibitor
  • /internalmedicine/article/241131/lung-cancer/nsclc-immune-related-aes-during-checkpoint-inhibitor
  • /chestphysician/article/241131/lung-cancer/nsclc-immune-related-aes-during-checkpoint-inhibitor